505 related articles for article (PubMed ID: 18573340)
21. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
22. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy.
Kepp O; Galluzzi L; Martins I; Schlemmer F; Adjemian S; Michaud M; Sukkurwala AQ; Menger L; Zitvogel L; Kroemer G
Cancer Metastasis Rev; 2011 Mar; 30(1):61-9. PubMed ID: 21249425
[TBL] [Abstract][Full Text] [Related]
23. Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.
Chaput N; De Botton S; Obeid M; Apetoh L; Ghiringhelli F; Panaretakis T; Flament C; Zitvogel L; Kroemer G
J Mol Med (Berl); 2007 Oct; 85(10):1069-76. PubMed ID: 17891368
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin-like transcript 3: A crucial regulator of dendritic cell function.
Vlad G; Chang CC; Colovai AI; Berloco P; Cortesini R; Suciu-Foca N
Hum Immunol; 2009 May; 70(5):340-4. PubMed ID: 19275918
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells.
Brusa D; Migliore E; Garetto S; Simone M; Matera L
Prostate; 2009 Sep; 69(12):1343-52. PubMed ID: 19496055
[TBL] [Abstract][Full Text] [Related]
26. [Antitumoral immunization during cancer chemotherapy].
Zitvogel L; Hannani D; Aymeric L; Kepp O; Martins I; Kroemer G
Bull Acad Natl Med; 2012 Jun; 196(6):1075-86. PubMed ID: 23596856
[TBL] [Abstract][Full Text] [Related]
27. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
Garg AD; Nowis D; Golab J; Vandenabeele P; Krysko DV; Agostinis P
Biochim Biophys Acta; 2010 Jan; 1805(1):53-71. PubMed ID: 19720113
[TBL] [Abstract][Full Text] [Related]
28. Dendritic cell-based cancer immunotherapies.
Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
[TBL] [Abstract][Full Text] [Related]
29. Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.
Kono K; Mimura K; Kiessling R
Cell Death Dis; 2013 Jun; 4(6):e688. PubMed ID: 23788045
[TBL] [Abstract][Full Text] [Related]
30. Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all.
van der Most RG; Currie AJ; Robinson BW; Lake RA
Cell Death Differ; 2008 Jan; 15(1):13-20. PubMed ID: 18007666
[TBL] [Abstract][Full Text] [Related]
31. Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells.
Apetoh L; Obeid M; Tesniere A; Ghiringhelli F; Fimia GM; Piacentini M; Kroemer G; Zitvogel L
Cancer Genomics Proteomics; 2007; 4(2):65-70. PubMed ID: 17804868
[TBL] [Abstract][Full Text] [Related]
32. Pattern recognition receptors in the immune response against dying cells.
Jeannin P; Jaillon S; Delneste Y
Curr Opin Immunol; 2008 Oct; 20(5):530-7. PubMed ID: 18555676
[TBL] [Abstract][Full Text] [Related]
33. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.
Fransen JH; Hilbrands LB; Ruben J; Stoffels M; Adema GJ; van der Vlag J; Berden JH
Arthritis Rheum; 2009 Aug; 60(8):2304-13. PubMed ID: 19644874
[TBL] [Abstract][Full Text] [Related]
34. New data cheer champions of the danger theory.
Holzman DC
J Natl Cancer Inst; 2010 Jan; 102(2):76-8. PubMed ID: 20054018
[No Abstract] [Full Text] [Related]
35. [Unveiling antigens in a non-immunogenic spontaneous murine tumor using a dendritic cell based vaccine].
Reffo VL; Chiarella P; Bruzzo J; Bustuoabad OD; Ruggiero RA
Medicina (B Aires); 2008; 68(4):301-4. PubMed ID: 18786887
[TBL] [Abstract][Full Text] [Related]
36. Short-term administration of ethanol in mice deviates antigen presentation activity towards B cells.
Andrade MC; Albernaz MJ; Araújo MS; Santos BP; Teixeira-Carvalho A; Faria AM; Martins-Filho OA
Scand J Immunol; 2009 Sep; 70(3):226-37. PubMed ID: 19703012
[TBL] [Abstract][Full Text] [Related]
37. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
[TBL] [Abstract][Full Text] [Related]
38. Partial role of TLR4 as a receptor responding to damage-associated molecular pattern.
Lee KM; Seong SY
Immunol Lett; 2009 Jun; 125(1):31-9. PubMed ID: 19501120
[TBL] [Abstract][Full Text] [Related]
39. The heat shock protein Gp96 links innate and specific immunity.
Hilf N; Singh-Jasuja H; Schild H
Int J Hyperthermia; 2002; 18(6):521-33. PubMed ID: 12537752
[TBL] [Abstract][Full Text] [Related]
40. Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer.
Kusume A; Sasahira T; Luo Y; Isobe M; Nakagawa N; Tatsumoto N; Fujii K; Ohmori H; Kuniyasu H
Pathobiology; 2009; 76(4):155-62. PubMed ID: 19571604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
